Zum Hauptinhalt springen
Hochschulbibliothek der Hochschule Düsseldorf

Suchergebnisse

Katalog

Mehr
220 Treffer

Suchmaske

Suchtipp für den Bereich Mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Das folgende Suchfeld wird hier nicht unterstützt: "Signatur".

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Art der Quelle

Thema

Sprache

Inhaltsanbieter

220 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    Researchers from Department of Oncology Report on Findings in Non-Small Cell Lung Cancer (Comparative efficacy of immune checkpoint inhibitors combined with chemotherapy in patients with advanced driver-gene negative non-small cell lung cancer:...).
    In: Immunotherapy Weekly, 2024-05-27, S. 706-706
    serialPeriodical
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    Integrated Analyses of Multi-omic Data Derived from Paired Primary Lung Cancer and Brain Metastasis Reveals the Metabolic Vulnerability as a Novel Therapeutic Target.
    In: Immunotherapy Weekly, 2024-01-16, S. 150-150
    serialPeriodical
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    Patent Issued for Method of treating lung cancer (USPTO 11767361).
    In: Immunotherapy Weekly, 2023-10-17, S. 1641-1641
    serialPeriodical
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    Reports from Tongji University Add New Study Findings to Research in Non-Small Cell Lung Cancer (Research Progress on Combination of Radiotherapy and Immunotherapy on Advanced Non-small Cell Lung Cancer with Negative Driver Genes).
    In: Immunotherapy Weekly, 2023-10-17, S. 806-806
    serialPeriodical
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    Data on Non-Small Cell Lung Cancer Detailed by a Researcher at Chonnam National University Hwasun Hospital (Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY...).
    In: Immunotherapy Weekly, 2023-05-16, S. 178-178
    serialPeriodical
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    Researchers at Tangshan People's Hospital Zero in on Lung Cancer (Gene set variation analysis-based aging and senescence score as a prognostic indicator and therapeutic guide in lung adenocarcinoma).
    In: Immunotherapy Weekly, 2023-07-20, S. 1184-1184
    serialPeriodical
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    Research from Guangxi Medical University Cancer Hospital Yields New Study Findings on Lung Cancer (Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR...).
    In: Immunotherapy Weekly, 2023-07-20, S. 1050-1050
    serialPeriodical
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    Shaoyang University Researchers Report Research in Lung Cancer (Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma).
    In: Immunotherapy Weekly, 2023-04-18, S. 1127-1127
    serialPeriodical
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    Research Findings from Tianjin Medical University Cancer Institute and Hospital Update Understanding of Lung Cancer (A novel pyroptosis-related prognostic signature for lung adenocarcinoma: Identification and multi-angle verification).
    In: Immunotherapy Weekly, 2023-04-18, S. 861-861
    serialPeriodical
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    A Study to Learn More About How Well BAY 2927088 Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Human Epidermal Growth Factor Receptor 2 (HER2.
    In: Immunotherapy Weekly, 2024-06-25, S. 170-170
    serialPeriodical
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    A Multi-center, Prospective, Exploratory Study Evaluating the Efficacy and Safety of a Modified Si Jun Zi Tang Formula in the Perioperative Treatment of Non-small Cell Lung Cancer.
    In: Immunotherapy Weekly, 2024-06-25, S. 44-44
    serialPeriodical
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    Single-cell and spatial transcriptome characterize coinhibitory cell-cell communications during histological progression of lung adenocarcinoma.
    In: Immunotherapy Weekly, 2024-06-25, S. 1460-1460
    serialPeriodical
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    An Investigator-initiated Trial Evaluating the Efficacy and Safety of Anti-Trop2 Universal CAR-NK(U-CAR-NK) Cells Therapy Combined With Chemotherapy for Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC).
    In: Immunotherapy Weekly, 2024-06-25, S. 201-201
    serialPeriodical
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    Gumarontinib Combined With Third-generation EGFR-TKI in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With MET Amplification Following EGFR-TKI Treatment Failure.
    In: Immunotherapy Weekly, 2024-06-25, S. 484-484
    serialPeriodical
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    Patent Issued for Selection of patients for combination therapy (USPTO 12000829).
    In: Immunotherapy Weekly, 2024-06-25, S. 1947-1947
    serialPeriodical
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    Recent Findings from University of California Davis Provides New Insights into Non-Small Cell Lung Cancer (Targeting Mek In Non-small Cell Lung Cancer).
    In: Immunotherapy Weekly, 2024-06-25, S. 881-881
    serialPeriodical
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    Data on Non-Small Cell Lung Cancer Reported by a Researcher at North China University of Science and Technology (To establish a prognostic model of epidermal growth factor receptor mutated non-small cell lung cancer patients based on Least...).
    In: Immunotherapy Weekly, 2024-06-25, S. 329-329
    serialPeriodical
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    Study Findings on Lung Cancer Are Outlined in Reports from North Sichuan Medical College (Investigation of RBM10 mutation and its associations with clinical and molecular characteristics in EGFR-mutant and EGFR-wildtype lung adenocarcinoma).
    In: Immunotherapy Weekly, 2024-06-25, S. 1438-1438
    serialPeriodical
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    Findings from Shandong Cancer Hospital and Institute Broaden Understanding of Personalized Medicine (Clinically Relevant Immune Subtypes Based On Alternative Splicing Landscape of Immune-related Genes for Lung Cancer Advanced Pppm Approach).
    In: Immunotherapy Weekly, 2024-06-25, S. 422-422
    serialPeriodical
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    Studies in the Area of Non-Small Cell Lung Cancer Reported from Naval Medical University (Immunotherapy-based Regimens for Patients With Egfr-mutated Non-small Cell Lung Cancer Who Progressed On Egfr-tki Therapy).
    In: Immunotherapy Weekly, 2024-06-25, S. 1387-1387
    serialPeriodical
    Wie komme ich dran?

Weitere Bibliothekskataloge

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -